About us

Our patented method and the future

Our company is currently transitioning into the commercialization phase and actively preparing for CE marking in accordance with MDR Class 2A requirements. At present, Profundus employs a dedicated team of seven professionals and is situated in the BioVentureHub, an esteemed innovation center hosted by AstraZeneca, located in Mölndal, Sweden. We are proud to have garnered financial support from both institutional and private investors.

The foundation of Profundus stems from a collaborative effort between four innovative researchers. Jörgen Thaung and Zoran Popovic, engineers with Master of Science degrees from Chalmers University of Technology and doctoral qualifications from the University of Gothenburg, recognized the need for an enhanced method of eye diagnostics during their research at the university’s ophthalmology department. They connected with Associate Professor Mette Owner-Petersen and PhD candidate Per Knutsson, who were part of a research group at the department of Astronomy and Astrophysics at Lund University who were working on multi-conjugate adaptive optics for ground-based telescope applications.

These four researchers leveraged their respective expertise, allowing the ophthalmology specialists to access unique knowledge while affording the astronomers the opportunity to witness the implementation of their technology first-hand. Together, they addressed a range of advanced technical challenges, culminating in the development of a patented method for advanced eye diagnostics.